Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E18.15 EPS (ttm)2.40 Insider Own0.10% Shs Outstand5.80B Perf Week0.02%
Market Cap252.47B Forward P/E14.19 EPS next Y3.07 Insider Trans-12.18% Shs Float5.80B Perf Month-1.89%
Income14.41B PEG2.41 EPS next Q0.65 Inst Own74.20% Short Float0.80% Perf Quarter3.47%
Sales53.37B P/S4.73 EPS this Y68.20% Inst Trans0.46% Short Ratio2.13 Perf Half Y21.02%
Book/sh12.14 P/B3.59 EPS next Y2.03% ROA14.20% Target Price43.79 Perf Year23.14%
Cash/sh2.97 P/C14.65 EPS next 5Y7.52% ROE33.70% 52W Range33.20 - 45.81 Perf YTD20.18%
Dividend1.36 P/FCF27.53 EPS past 5Y10.40% ROI11.00% 52W High-5.76% Beta0.86
Dividend %3.12% Quick Ratio1.20 Sales past 5Y-0.80% Gross Margin79.10% 52W Low30.03% ATR1.03
Employees90200 Current Ratio1.40 Sales Q/Q1.00% Oper. Margin26.40% RSI (14)47.11 Volatility2.23% 2.51%
OptionableYes Debt/Eq0.58 EPS Q/Q45.80% Profit Margin44.60% Rel Volume1.00 Prev Close43.53
ShortableYes LT Debt/Eq0.47 EarningsOct 30 BMO Payout33.40% Avg Volume21.84M Price43.17
Recom2.70 SMA20-0.56% SMA50-1.30% SMA20011.09% Volume7,818,694 Change-0.83%
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Nov-21-18 10:00AM  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
09:44AM  FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz Zacks
06:00AM  5 Quality Blue Chips to Thrive in Bull and Bear Markets Investopedia
02:08AM  [$$] Global markets retreat as tech rout spreads Financial Times
Nov-20-18 04:24PM  Corcept Initiates Phase III Study for Cushing's Syndrome Zacks
03:30PM  [$$] Diversis Capital Buys Controlling Stake of Tempo The Wall Street Journal
08:12AM  Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails Zacks
06:00AM  Pfizer and 3 Other Stock Picks From a 5-Star Growth Fund
Nov-19-18 06:08PM  Stock Market Today: Sea of Red Investopedia
05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
05:15PM  Nasdaq Slides More Than 3% As These Dow Blue Chips Buck The Broad Sell-Off Investor's Business Daily
05:08PM  Pfizer Shares Jump on Monday After Company Signals Higher Price Push
04:29PM  Pfizer to raise drug prices despite Trumps complaints Fox Business Videos
04:23PM  Tech Selloff Could Work in Favor of Pharmaceutical Stocks
04:21PM  Pfizer's Ovarian Cancer Treatment Fails In Late-Stage Test Investor's Business Daily
03:23PM  3 Steady Healthcare Stocks to Hold During a Downturn InvestorPlace
03:01PM  Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing
01:12PM  Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility
12:54PM  Pfizer Lifting Prices on 41 Drugs in 2019 Investopedia
12:32PM  Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth
11:43AM  Jim Cramer Reacts to Pfizer's Drug Hikes
10:26AM  Stocks - Apple Falls in Pre-market; Nissan, Renault, PG&E, Sink
09:43AM  Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension Zacks
09:35AM  Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs Zacks
09:30AM  Pfizer Stock Slides Slightly as Drug-Maker Prepares Price Increases
09:30AM  Pfizer Could Rally in the Weeks Ahead as Investors Look Beyond Today's Headline
08:18AM  The Zacks Analyst Blog Highlights: Pfizer, Cisco, Southern, SunTrust Banks and AmerisourceBergen Zacks
07:38AM  Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial MarketWatch
07:12AM  Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer PR Newswire
06:50AM  Today's Research Reports on Trending Tickers: Facebook and Pfizer ACCESSWIRE
06:27AM  Carlos Ghosn, Apple, US-China Trade, Bitcoin and Pfizer - 5 Things You Must Know
Nov-17-18 05:04PM  Where Will Pfizer Inc. Be in 5 Years? Motley Fool
03:42PM  Pfizer Plans Price Hikes for 41 Drugs Next Year
Nov-16-18 07:50PM  [$$] Pfizer to Raise Prices on 41 Drugs in January The Wall Street Journal
06:49PM  [$$] Pfizer to Raise Prices on 41 Drugs The Wall Street Journal
05:22PM  Pfizer to raise US drug prices in January after previously backing down Reuters
04:47PM  Pfizer to raise drug prices in January American City Business Journals
04:35PM  Pfizer to raise prices on 41 drugs: report MarketWatch
03:24PM  Pfizer to raise prices on 41 prescription drugs next year despite pressure from Trump CNBC
03:23PM  Pfizer plans to increase U.S. drug prices in January Reuters
01:04PM  Final Trades: Virtu, JPMorgan & Pfizer CNBC Videos
08:31AM  AstraZeneca Shows It Can Still Take Some Knocks Bloomberg
04:42AM  [$$] Pfizer to raise prices for 41 drugs despite Trump criticism Financial Times
Nov-15-18 09:50AM  MARKETS: Stocks could bounce here, but I'm selling the rally Yahoo Finance Video
09:44AM  Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes Zacks
08:49AM  Why Pfizer Is Up 19% in 2018 So Far Motley Fool
12:00AM  3 Dividend Stocks Ideal for Retirees Motley Fool
Nov-14-18 05:54PM  Here's Why Sangamo Therapeutics Lost 12% Today Motley Fool
02:59PM  Pfizer loses drug patent fight in UK top court, may face claims Reuters
02:02PM  7 Highest-Yielding Dow Dividend Stocks Kiplinger
06:31AM  Pfizer loses blockbuster drug patent fight in UK Supreme Court Reuters
05:01AM  Pfizer loses Lyrica drug patent fight in UK Supreme Court Reuters
Nov-13-18 07:00AM  Walmart, Home Depot adopt health insurer tactic in drug copay battle Reuters
Nov-12-18 05:45PM  Pfizer (PFE) Stock Moves -0.38%: What You Should Know Zacks
04:21PM  These Biopharmas Could Cure Genetic Diseases At $5 Million Apiece Investor's Business Daily
Nov-11-18 01:40PM  Hedge Funds Continue to Sell Off Pfizer Inc. (PFE) Insider Monkey
06:37AM  Better Buy: Amgen Inc. vs. Pfizer Inc. Motley Fool
Nov-09-18 07:31AM  Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug Zacks
Nov-08-18 07:32PM  ICU Medical Inc (ICUI) Q3 2018 Earnings Conference Call Transcript Motley Fool
10:43AM  Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up Zacks
04:39AM  AstraZeneca sees years of growth as drug sales turn corner Reuters
Nov-07-18 09:25PM  Nektar Therapeutics (NKTR) Q3 2018 Earnings Conference Call Transcript Motley Fool
04:09PM  These 5 Dow Jones Stocks Just Made This Bullish Move Investor's Business Daily
02:39PM  MARKETS: Oil heading into bear market territory Yahoo Finance Video
12:42PM  Pfizer Rises 3%
12:16PM  'We have a lot of things in common' Trump wants to work with Democrats on infrastructure, drugs CNBC
11:30AM  Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election Benzinga
11:10AM  NMC Healthcare Sukuk Limited -- Moody's assigns Ba1 rating to NMC's trust certificates Moody's
Nov-06-18 05:45PM  Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
04:20PM  MARKETS: Pharma stocks making moves ahead of midterms Yahoo Finance Video
03:15PM  Eli Lilly's Conservative Pricing Offers Protection From Political Pressure
08:30AM  New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers PR Newswire
Nov-05-18 04:03PM  Bulls & Bears Of The Week: Amazon, Apple, Ford, GE And More Benzinga
02:28PM  Biogen Stock Rebounds After Impressive Q3 Earnings InvestorPlace
10:00AM  Hedge Funds Are Piling Into This Stock Insider Monkey
Nov-02-18 06:34PM  FDA approves Pfizer's treatment for certain lung cancer patients Reuters
05:18PM  Stocks finish lower after a volatile trading session Yahoo Finance Video
04:42PM  U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC Business Wire
11:41AM  Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO Zacks
10:50AM  AbbVie Earnings, Revenue beat in Q3
08:10AM  Report: Exploring Fundamental Drivers Behind Pfizer, eBay, ABM Industries, Quad Graphics, FireEye, and BJ's Restaurants New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
08:09AM  Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus Zacks
06:55AM  Dow 30 Stock Roundup: Apple, Coca-Cola, DowDuPont Earnings Impress Zacks
Nov-01-18 06:31PM  Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine Zacks
01:28PM  Pfizer cut to market perform at BMO CNBC Videos
12:18PM  BMO: Significant Headwinds Will Cap Pfizer Upside Investopedia
10:54AM  BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced' Benzinga
10:52AM  Edited Transcript of PFE earnings conference call or presentation 30-Oct-18 2:00pm GMT Thomson Reuters StreetEvents
10:50AM  Has Pfizer (PFE) Outpaced Other Medical Stocks This Year? Zacks
10:08AM  Zoetis Inc Earnings, Revenue beat in Q3
09:55AM  3 Pharma Stocks to Make a Portfolio Feel Better Investopedia
09:43AM  Pfizer weighing sale of women's health portfolio - Bloomberg Reuters
08:46AM  Here's What Exact Sciences Just Said About Its Future Motley Fool
08:21AM  Pfizer downgraded by BMO: 'Significant headwinds' will cap the drugmaker's stock run CNBC
07:45AM  Stocks making the biggest move premarket: DWDP, NFX, ECA, AAPL, CI & more CNBC
07:33AM  Pfizer will go back to price hikes as normal come January, CEO suggests MarketWatch
Oct-31-18 06:28PM  Baxter Earnings beat, Revenue misses In Q3
12:29PM  10 Hot Stocks to Buy Right Now InvestorPlace
12:27PM  Big Pharma's Price Freezes Aren't Fooling Anybody Bloomberg
08:00AM  Todays Research Reports on Stocks to Watch: Daxor and Pfizer ACCESSWIRE
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brands. This segment also engages in the research and development, as well as contract manufacturing activities. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; Immutep Limited; BioNTech AG; Neofluidics, LLC; Kite Pharma, Inc.; Merck KGaA; Leap Therapeutics, Inc.; and Nektar Therapeutics, as well as development agreement with Antares Pharma, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM
OLSON LAURIE JExecutive Vice PresidentJun 06Sale36.4519,000692,58282,886Jun 08 01:11 PM
CORNWELL W DONDirectorJun 04Sale36.405,223190,1170Jun 05 04:44 PM
READ IAN CChairman & CEOMay 01Sale36.01132,3124,764,0811,144,703May 03 04:19 PM
JOHNSON RADY AExecutive Vice PresidentMar 13Sale36.5527,323998,66643,178Mar 14 05:19 PM
LANKLER DOUGLAS MExecutive Vice PresidentMar 13Sale36.8950,0001,844,39883,857Mar 14 05:13 PM
Dolsten MikaelPresident R&DMar 09Sale36.5969,6992,550,39451,185Mar 12 05:01 PM
HILL CHARLES HExecutive Vice PresidentMar 06Sale35.7642,3931,515,98557,328Mar 07 04:09 PM
Dolsten MikaelPresident R&DMar 02Sale35.8513,986501,398120,884Mar 05 09:23 AM
HILL CHARLES HExecutive Vice PresidentFeb 28Option Exercise27.37101,8722,788,237207,942Mar 02 03:24 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37121,1453,315,739362,707Mar 02 04:10 PM
OLSON LAURIE JExecutive Vice PresidentFeb 28Option Exercise27.3738,5461,055,004132,702Mar 02 04:02 PM
READ IAN CChairman & CEOFeb 28Option Exercise27.37649,78017,784,4791,774,184Mar 02 04:03 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.37110,1323,014,313245,362Mar 02 04:03 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50239,801Mar 02 03:44 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50285,910Mar 02 03:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3746,8061,281,080171,276Mar 02 03:44 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 28Option Exercise27.37104,6262,863,614384,219Mar 02 03:44 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37209,2515,727,200655,161Mar 02 03:24 PM
BOURLA ALBERTChief Operating OfficerFeb 28Option Exercise27.3739,9231,092,693184,120Mar 02 03:24 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3733,040904,305136,847Mar 02 03:24 PM
Dolsten MikaelPresident R&DFeb 28Option Exercise27.37198,2385,425,774293,352Mar 02 03:24 PM
HILL CHARLES HExecutive Vice PresidentFeb 28Sale36.8326,779986,292181,163Mar 02 03:24 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Sale37.0333,3681,235,591135,230Feb 28 06:14 PM
Dolsten MikaelPresident R&DFeb 27Sale37.0464,5872,392,31395,114Feb 28 06:04 PM
CORNWELL W DONDirectorFeb 27Sale37.0530011,1150Feb 28 01:29 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 26Sale37.199,510353,67717,770Feb 27 07:38 PM
CORNWELL W DONDirectorFeb 26Sale36.741,45853,5640Feb 28 01:29 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9043,520822,528223,733Feb 27 08:59 PM
READ IAN CChairman & CEOFeb 24Option Exercise19.83903,55917,917,2651,560,007Feb 27 08:58 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9015,716297,03290,222Feb 27 07:53 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456206,972Feb 27 07:51 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9015,885300,22762,848Feb 27 07:43 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9028,288534,643112,081Feb 27 07:43 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456313,499Feb 27 07:43 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 24Option Exercise18.9015,957301,58736,959Feb 27 07:38 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 24Option Exercise18.9039,555747,590143,152Feb 27 07:38 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9065,2801,233,792122,609Feb 27 07:38 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90174,0813,290,131225,265Feb 27 07:32 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9028,288534,643116,769Feb 27 07:30 PM
BOURLA ALBERTChief Operating OfficerFeb 24Option Exercise18.9025,387479,814158,170Feb 27 07:30 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90174,0813,290,131511,470Feb 27 07:30 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 15Sale37.006,750249,750103,458Dec 18 06:17 PM
JOHNSON RADY AExecutive Vice PresidentDec 15Sale37.078,000296,56046,963Dec 18 06:17 PM